Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma-Reference-Cited by-同舟云学术

Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma

Published:2002-09-11 Issue:2-3 Volume:529 Page:232-236
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:

Author:

Gourdier Isabelle,Del Rio Maguy,Crabbé Laure,Candeil Laurent,Copois Virginie,Ychou Marc,Auffray Charles,Martineau Pierre,Mechti Nadir,Pommier Yves,Pau Bernard

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Reference24 articles.

1. Are there several colorectal cancers? Epidemiological data

2. Cancer statistics, 2000

3. EDUCATIONAL SECTION: Novel chemotherapeutic agents in colorectal cancer

4. The changing face of chemotherapy in colorectal cancer

5. Oxaliplatin

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy;Molecules;2024-05-02

2. Oxaliplatin and its derivatives – An overview;Coordination Chemistry Reviews;2023-12

3. Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells;Cell & Bioscience;2023-04-11

4. Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives;International Journal of Molecular Sciences;2022-12-06

5. Improvement of resistance to oxaliplatin by vorinostat in human colorectal cancer cells through inhibition of Nrf2 nuclear translocation;Biochemical and Biophysical Research Communications;2022-06